Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023

BUY
$104.0 - $122.92 $349,440 - $413,011
3,360 Added 90.79%
7,061 $820,000
Q4 2022

Jan 18, 2023

BUY
$84.98 - $122.67 $83,875 - $121,075
987 Added 36.37%
3,701 $0
Q3 2022

Oct 11, 2022

SELL
$76.35 - $94.18 $258,215 - $318,516
-3,382 Reduced 55.48%
2,714 $219,000
Q2 2022

Jul 14, 2022

BUY
$67.99 - $132.89 $247,687 - $484,118
3,643 Added 148.51%
6,096 $454,000
Q1 2022

Jul 14, 2022

BUY
$94.08 - $130.2 $33,586 - $46,481
357 Added 17.03%
2,453 $1.26 Million
Q4 2021

Jan 19, 2022

BUY
$129.87 - $162.82 $10,519 - $13,188
81 Added 4.02%
2,096 $1.13 Million
Q3 2021

Oct 15, 2021

BUY
$106.71 - $143.18 $8,856 - $11,883
83 Added 4.3%
2,015 $1.1 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $24,297 - $32,379
300 Added 18.38%
1,932 $966,000
Q1 2021

Apr 15, 2021

SELL
$84.79 - $104.74 $42,479 - $52,474
-501 Reduced 23.49%
1,632 $567,000
Q4 2020

Jan 25, 2021

SELL
$78.0 - $104.5 $4,056 - $5,434
-52 Reduced 2.38%
2,133 $789,000
Q3 2020

Oct 15, 2020

BUY
$95.51 - $112.95 $668 - $790
7 Added 0.32%
2,185 $901,000
Q2 2020

Jul 28, 2020

SELL
$62.68 - $105.34 $63,306 - $106,393
-1,010 Reduced 31.68%
2,178 $883,000
Q1 2020

Apr 21, 2020

SELL
$47.79 - $75.63 $17,538 - $27,756
-367 Reduced 10.32%
3,188 $858,000
Q4 2019

Feb 03, 2020

SELL
$36.62 - $57.29 $11,645 - $18,218
-318 Reduced 8.21%
3,555 $778,000
Q3 2019

Oct 10, 2019

SELL
$35.53 - $43.8 $1,563 - $1,927
-44 Reduced 1.12%
3,873 $578,000
Q2 2019

Jul 16, 2019

BUY
$27.84 - $38.92 $109,049 - $152,449
3,917 New
3,917 $587,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33.2B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Juncture Wealth Strategies, LLC Portfolio

Follow Juncture Wealth Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Juncture Wealth Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Juncture Wealth Strategies, LLC with notifications on news.